![]() |
市场调查报告书
商品编码
1520525
2024-2032 年按类型、应用、最终用户和地区分類的製药机器人市场报告Pharmaceutical Robots Market Report by Type, Application, End User, and Region 2024-2032 |
IMARC Group年,全球製药机器人市场规模达1.985亿美元。对药品的需求不断增长、机器人技术的新兴技术进步以及为确保生产过程中产品安全和品质而实施严格的监管框架是推动市场的一些主要因素。
主要市场驱动因素:製药机器人市场的扩大主要是由于药物需求的增加,这可归因于老年人口的增长和慢性病病例的增加。此外,製造流程效率、精度和生产力的提高进一步刺激了市场成长。
主要市场趋势:机器人技术应用于最精确的任务,包括药物配方和包装。将人工智慧和机器学习等先进技术整合到机器人技术中可以提高营运效率并减少人为错误。
地理趋势:由于不断的工业扩张和对医疗保健技术的巨大投资,亚太地区正在成为最大的市场参与者。中国、日本和韩国等其他一些国家在这一领域处于领先地位,因为它们的政府支持将机器人解决方案与先进技术结合到製药中。
竞争格局:竞争格局的特点是产业主要参与者的参与,他们透过加强产品创新和与多个合作伙伴的合作定期提高其市场地位。虽然这些公司显然正在投资技术创新,但他们也决心提高客户支援和服务的标准,以巩固他们在市场上的地位。
挑战与机会:市场面临挑战,包括高昂的前期成本以及将机器人与现有系统整合所带来的复杂性,但同时也提供了大量机会。基于创建更灵活和可扩展的机器人解决方案,可以满足不断发展的行业的需求并跟上不断变化的法规,因此存在充足的成长机会。
医药产品的需求不断增长
由于机器人技术的使用驱动机械集成,製药业发生了巨大的转变,直接导致製药机器人市场的成长。随着全球人口老化和慢性病的增加,对药品的需求不断增加。这带动了市场需求。医学的巨大成长进一步增强了这一点,将创新药物疗法纳入其可以对抗的疾病清单中,包括个人化药物和复杂的生物製药。借助机器人技术,药品製造过程实现了效率和准确性的提高,从而提高了製药机器人的市场份额。根据国际机器人联合会(IFR)的数据,全球专业服务机器人市场营业额达67亿美元,2020年成长12%。
机器人技术的新兴技术进步
配备感测和控制能力等先进技术的机器人可以提高药品製造和配药等流程的精度和标准化。这种能力可以最大限度地减少人为错误,并显着提高产品品质和患者安全,这是製药机器人市场的主要趋势之一。机器人技术的发展至关重要,因为它们有助于解决製药业面临的挑战。机器人的使用还可以取代劳动密集和重复性任务,从而最大限度地提高资源利用率,从而加快生产週期。主要公司为提高效率和生产力而进行的转变有助于他们产生更高的製药机器人市场收入。
实施严格的监管框架
监管机构透过建立严格的法律架构构成市场的重要决定因素。这些法规规定了药品的安全性、有效性和质量,迫使药厂采用机器人技术来满足既定要求。製药业的机器人技术由具有与工业自动化领域类似功能的技术组成,包括即时监控和资料记录,这对于确保自动化製药过程的合规性和可靠性至关重要。这些技术的实施对于满足监管机构规定的严格要求起着至关重要的作用,这凸显了製药机器人市场分析。
IMARC Group提供了全球製药机器人市场报告各细分市场主要趋势的分析,以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据类型、应用程式和最终用户对市场进行了分类。
传统机器人
关节式机器人
SCARA机器人
台达/并联机器人
笛卡儿机器人
双臂机器人
协作製药机器人
传统机器人代表最受欢迎的类型
该报告根据类型提供了详细的市场细分和分析。这包括传统机器人(铰接式机器人、SCARA机器人、三角/并联机器人、直角座标机器人、双臂机器人)和协作製药机器人。报告显示,传统机器人占据最大的市场。
传统机器人是製药业最常使用的机器人类型,机器人自动执行日常流程的任务。此类机器人因其无与伦比的能力而被广泛应用于製药行业,因为它们在处理製药製造中通常需要的不同类型的自动化任务方面已经证明了可靠性和效率。市场报告显示,机器人的多方面工作和准确度是其突出的原因,占据了相当大的市场份额。製药机器人市场预测显示,传统机器人仍是最受欢迎的类型,这得益于各大品牌不断升级和提高效率,试图渗透到更复杂的製药流程。
拣选和包装
药品检验
实验室应用
拣选和包装目前占据最大的市场份额
报告还提供了基于应用程式的详细市场细分和分析。这包括拣选和包装、药品检查以及实验室应用。报告称,拣选和包装占据了最大的市场份额。
製药机器人市场概况表明,涉及拣选和包装的这些操作是最主要的应用。该细分市场受益于机器人技术的实施,因为这些系统提高了药品包装的速度、准确性和一致性。此外,未来的市场机会可能会透过机器人的进一步设计创新来处理和减少停机时间,从而提高药品製造的整体生产力。製药业市场报告强调了该技术在此类製造过程中提供的优势,特别是在提高生产效率和降低营运成本方面。
製药公司
研究实验室
製药公司占最大的市场份额
报告还提供了基于最终用户的详细市场细分和分析。这包括製药公司和研究实验室。报告显示,製药公司占了最大的市场份额。
根据市场估计,製药公司在机器人市场中占有最大份额。他们利用机器人技术在生产、精确度以及遵守安全和健康标准和法规方面提出增强的应用。市场报告表明,随着越来越多的製药公司受到创新和成本效益的激励,机器人整合将变得更加成熟。製药机器人市场最近的机会包括机器人用途的开发,这可能会产生更客製化和复杂的解决方案,旨在满足製药生产商的特殊需求。
北美洲
美国
加拿大
亚太
中国
日本
印度
韩国
澳洲
印尼
其他的
欧洲
德国
法国
英国
义大利
西班牙
俄罗斯
其他的
拉丁美洲
巴西
墨西哥
其他的
中东和非洲
亚太地区在市场上表现出明显的主导地位
市场研究报告还对所有主要区域市场进行了全面分析,其中包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告称,亚太地区是製药机器人最大的区域市场。
亚太地区由于工业成长快速以及对医疗保健和药品製造的推动更加强烈,在市场上占据主导地位。根据製药机器人市场回顾,中国、日本和韩国这三个领先国家在製药操作中应用机器人技术处于领先地位。製药机器人报告描述了极大促进该领域区域市场扩张的政府行动和投资。由于药品需求的增加以及机器人领域的技术突破,亚太地区的製药机器人市场前景仍然乐观。根据自动化推进协会(A3)的报告,北美公司近年来订购了 44,196 台机器人,价值 23.8 亿美元,与 2021 年相比,数量增加了 11%,价值增加了 18%。
The global pharmaceutical robots market size reached US$ 198.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 445.0 Million by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. The rising demand for pharmaceutical products, the emerging technological advancement in robotics technology, and the implementation of stringent regulatory frameworks to ensure product safety and quality during production processes are some of the major factors propelling the market.
Major Market Drivers: The market for pharmaceutical robots is expanding primarily due to an increasing demand for medications, which can be attributed to the growing elderly population and a rise in chronic disease cases. Additionally, enhancements in the efficiency, precision, and productivity of manufacturing processes further stimulate market growth.
Key Market Trends: Robotic technology finds its application in the most accurate tasks including drugs formulation and packaging. Integrating the advanced technologies, such as AI and machine learning in robotics is improving operational efficiency and reducing the human error as well.
Geographical Trends: Asia Pacific is emerging as the biggest market player, due to the constant industrial expansion and huge investment in healthcare technology. Some other countries such as China, Japan, and South Korea are leading the way in this area, as their governments are backing the incorporation of robotic solutions with the advanced technologies into drug making.
Competitive Landscape: The rivalry landscape is characterized by the involvement of major players in the industry who increase their market positions periodically via enhanced product innovations and collaboration with multiple partners. While these companies are clearly investing in technological innovations, they are also determined to raise the bar in customer support and services to fortify their hold on the market.
Challenges and Opportunities: The market has challenges that include high upfront costs and the complexity that comes with integrating robots with existing systems, but at the same time provide numerous opportunities. There are ample growth opportunities based on creating more flexible and scalable robotic solutions which can serve the needs of growing industries and keep abreast with constantly changing regulations.
The rising demand for pharmaceutical products
The pharmaceutical industry witnesses a dramatic shift due to machinery integration driven by the use of robotics technology, directly leading to the pharmaceutical robots market growth. With the aging global population and rising chronic diseases, the demand for pharmaceuticals is rising. This drives the market demand. This is further augmented by tremendous growth in medicine that has incorporated innovative pharmacotherapies into the list of diseases that they can combat, including personalized medicines and complex biopharmaceuticals. With the help of robotics technology, the pharmaceutical manufacturing processes achieve an increase in efficiency and accuracy, and consequently improve the pharmaceutical robots market share. According to the International Federation of Robotics (IFR), the global market for professional service robots reached a turnover of $6.7 billion U.S. dollars, marking a 12% increase in 2020.
The emerging technological advancement in robotics technology
Robots equipped with advanced technologies, including sensing and control capabilities, enhance precision and standardization in processes such as drug manufacturing and dispensing. Such ability minimizes human error and considerably improve product quality and patient safety, which is one of the major pharmaceutical robots market trends. The developments in robotics technology are essential as they contribute to the solutions of the challenges facing the pharmaceutical industry. The employment of robots as well ensures the substitution of labor-intensive and repetitive tasks with them, hence maximizing resource utilization which in turn speeds up production cycle. This transition of the key companies to enhance their efficiencies and their productivity helps them generate higher pharmaceutical robots market revenue.
The implementation of stringent regulatory frameworks
Regulatory authorities constitute an important determinant for the market through the establishment of strict legal frameworks. These regulations stipulate the safety, efficacy, and quality of pharmaceutical products, forcing pharmaceutical manufacturers to adopt robotics technology to meet the set requirements. Robotics in pharmaceutical industry consist of technologies with functions that are similar to what is found within the industrial automation sector, including real time monitoring and data logging which are very essential in ensuring the compliance and satisfying the reliability of the automated pharmaceutical manufacturing processes. The implementation of these technologies plays a crucial role in satisfying the strict requirements prescribed by the regulatory authorities, which highlights the pharmaceutical robots market analysis.
IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical robots market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, application, and end user.
Traditional Robots
Articulated Robots
SCARA Robots
Delta/Parallel Robots
Cartesian Robots
Dual-arm Robots
Collaborative Pharmaceutical Robots
Traditional robots represent the most popular type used
The report has provided a detailed breakup and analysis of the market based on the type. This includes traditional robots (articulated robots, SCARA robots, delta/parallel robots, cartesian robots, dual-arm robots), and collaborative pharmaceutical robots. According to the report, traditional robots accounted for the largest market share.
Traditional robots are the most frequently used type of robots in the pharmaceutical industry where robots automate tasks for routine processes. Such robots are widely utilized in the pharmaceutical industry for their unmatched capacity due to their already proved reliability and efficiency in handling different types of automated tasks normally necessary in pharmaceutical manufacturing. The market report revealed that the multifaceted work of the robots which is consistent with accuracy has been the reason behind their prominence occupying a substantial portion of the market for themselves. The pharmaceutical robots market forecast shows that it remains the traditional robots to be the most preferred type, which can be attributed to constant upgrade and increase efficiency by major brands trying to penetrate in more complicated processes in pharmaceuticals.
Picking and Packaging
Inspection of Pharmaceutical Drugs
Laboratory Applications
Picking and packaging presently account for the largest market share
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. According to the report, picking and packaging accounted for the largest market share.
The pharmaceutical robots market overview unveils that these operations involved in picking and packaging are the top dominant applications. This segment benefits greatly from implementing robotics, as these systems improves speed, accuracy, and consistency in the packaging of pharmaceutical products. In addition, future market opportunities may be signified by further designed innovations in robot to handle and reduce the downtime, which can be as this to improve the whole productivity of pharmaceutical manufacturing. The pharmaceutical industry market report underlines the advantage which this technique provides in this kind of manufacturing processes especially on increased production efficiency along with reduced cost of operation.
Pharmaceutical Companies
Research Laboratories
Pharmaceutical companies hold the largest share of the market
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes pharmaceutical companies and research laboratories. According to the report, pharmaceutical companies accounted for the largest market share.
The pharmaceutical companies hold the biggest share in the robot's market, according to the market estimation. They utilize robotic technology to come up with enhanced applications in the area of production, precision, and adherence of the safety and health standards and regulations. The market report indicates that as more pharmaceutical companies are motivated by innovation and cost-efficiency, robotic integration will become even more established. Pharmaceutical robots market recent opportunities include the development of robotic uses that might give rise to more tailored and intricate solutions aimed to meet the particular needs of pharmaceutical producers.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for pharmaceutical robots.
Asia Pacific region holds the dominance in the market on account of the fast industrial growth and more intense push towards healthcare and pharmaceutical manufacturing. In line with the pharmaceutical robot market review, the three leading nations including China, Japan and South Korea are at the forefront in implementing robotics in pharmaceutical operations. The pharmaceutical robots report describes government actions and investments that greatly contribute to regional market expansion in this field. The pharmaceutical robots market outlook for Asia Pacific remains positive due to an increasing demand for pharmaceuticals along with technological breakthroughs witnessed in the field of robotics. According to a report from the Association for Advancing Automation (A3), North American companies ordered 44,196 robots, valued at $2.38 billion in a recent year, marking increases of 11% in units and 18% in value compared to 2021.
ABB Ltd.
DENSO Corporation
FANUC Corporation
Kawasaki Heavy Industries Ltd.
Kuka AG
Marchesini Group S.p.A
Mitsubishi Electric Corporation
Robert Bosch GmbH
Seiko Epson Corporation
Shibuya Corporation
Universal Robots A/S (Teradyne Inc.)
Yaskawa Electric Corporation
(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)
Key pharmaceutical robots companies are proactively strengthening their positions within the industry by leveraging the trend and push forward with innovation. These key players are investing heavily for the integration of the latest technologies such as artificial intelligence, machine learning, and advanced sensors into their robotics products. Moreover, the companies are focused on building customer relationships via all-inclusive support services such as training, maintenance, and troubleshooting which are so vital for high performance and customer satisfaction. Apart from customer service, these major players are seriously involved in thought leadership, which include publishing research papers, attending industry conferences, and hosting webinar. These activities allow them to improve their reputations and enhance their credibility and establish their trust in the marketplace is integral here. Such efforts are significant components of the pharmaceutical robots market recent developments.
In February 2021, Kawasaki Heavy Industries Ltd. announced the installation of Japan's first automated polymerase chain reaction (PCR) testing system for the coronavirus disease (COVID-19), which operates using Kawasaki-made robots, at Fujita Health University in Aichi Prefecture.
In February 2021, ABB Ltd. launched two new additions to its robot line-up and the firm expected a 90% increase in robot sales in China relying on cobots or collaborative robots for pharmaceutical automation, for faster, scalable, and energy efficient manufacturing.
In August 2022, Yaskawa Electric Corporation announced the opening of a brand-new robotic solution facility in Haryana, India which enables closer collaboration and accelerated development of solutions for the full range of industrial robotic applications offered by the company.